Form D · Other Investment Fund
Symbiotic Capital Life Science Credit Parallel Fund, L.P.
Los Angeles, CA · CIK 0001978727
Offering snapshot reported May 22, 2026 · SEC filing
- Reported sold
- $176M Indefinite offering
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $10M Reported outside-investor minimum
- First sale
- Jul 31, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2026 | Amendment | $176,400,000 | $0vs May 23, 2025 | 13 | SEC filing |
| May 23, 2025 | Amendment | $176,400,000 | $55,487,817vs May 24, 2024 | 13 | SEC filing |
| May 24, 2024 | Amendment | $120,912,183 | No comparison | 7 | SEC filing |
| May 26, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $1.2M (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-482762
Includes sales commission of Fund and affiliated fund.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Not applicable | None | ARTIST CAPITAL LLC · CRD 153937 |
Source: Form D, filed May 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
SYMBIOTIC CAPITAL LIFE SCIENCE CREDIT PARALLEL FUND, L.P.
Investment adviser: SYMBIOTIC CAPITAL MANAGEMENT CO. LLC
- Gross asset value
- $268M
- Beneficial owners
- 13
- ADV minimum commitment
- $10M
Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- Yes
ERNST & YOUNG LLP
PCAOB 42
CITIBANK, NA
LEI E57ODZWZ7FF32TWEFA76
ARTIST CAPITAL LLC
CRD 153937 · SEC 8-68598
Filing source
Form ADV 2079137 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-8896165568
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arie Belldegrun | Director |
| Himani Bhalla | Director |
| Joshua Bradley | Director |
| Russell Goldsmith | Director |
| Symbiotic Capital Life Science Credit Fund Gp, L.P. | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Los Angeles, CA, 90067